Accessibility: Skip TopNav
Zigakibart Treatment Results in Rapid and Sustained Reductions in IgA and Gd-IgA1 in Patients with IgA Nephropathy
Zigakibart produced rapid and sustained reductions in IgA and Gd-IgA1, the pathogenic variant of IgA nephropathy
Format
PNG
Source
Chinook Therapeutics, Inc.
Downloads
Original
Large
Medium
Small